Japan Home Infusion Therapy Market Size & Outlook
Japan home infusion therapy market, 2018-2030 (US$M)
Related Markets
Japan home infusion therapy market highlights
- The Japan home infusion therapy market generated a revenue of USD 1,614.2 million in 2023 and is expected to reach USD 3,080.5 million by 2030.
- The Japan market is expected to grow at a CAGR of 9.7% from 2024 to 2030.
- In terms of segment, anti-infective was the largest revenue generating application in 2023.
- Endocrinology is the most lucrative application segment registering the fastest growth during the forecast period.
Home infusion therapy market data book summary
| Market revenue in 2023 | USD 1,614.2 million |
| Market revenue in 2030 | USD 3,080.5 million |
| Growth rate | 9.7% (CAGR from 2023 to 2030) |
| Largest segment | Anti-infective |
| Fastest growing segment | Endocrinology |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
| Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
Other key industry trends
- In terms of revenue, Japan accounted for 4.5% of the global home infusion therapy market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan home infusion therapy market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,171.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Home Infusion Therapy Market Scope
Home Infusion Therapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan home infusion therapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.76% in 2023. Horizon Databook has segmented the Japan home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
Japan held a substantial share of the market in Asia Pacific in 2021 owing to the increasing number of initiatives by the government to improve the overall healthcare system in the country. For instance, government home healthcare program was initiated in Japan in 2018 to make home care solutions more viable.
Moreover, there was an increase in reimbursement for home-based parenteral, enteral nutrition, and pain management therapy. Therefore, the home infusion therapy market in Japan is expected to grow during the forecast period.
Reasons to subscribe to Japan home infusion therapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan home infusion therapy market databook
-
Our clientele includes a mix of home infusion therapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into Japan home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan home infusion therapy market size, by application, 2018-2030 (US$M)
Japan Home Infusion Therapy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
